Multispecific antibodies are emerging as a leading class of biological therapeutics, with AstraZeneca at the forefront of protein engineering to deliver next generation targeted therapeutics across disease areas.
Preferences
Would you like to share some personal information with us so we can improve your experience on Researchalize.org?
